Quarterly report · Q1
4576.TEDINET S100QP3F
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥90m | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥448m | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥110m | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥101m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥38m | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥101m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥296m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥26m | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥101m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥26m | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥98m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥430m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥22m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥102m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥27m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥2.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥2.4bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥953m | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-3.14 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.5 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.74 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 66.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 262
| Item | Context | Value | Unit |
|---|---|---|---|
| Ordinary income | Prior1YTDDuration | -26107000 | JPY |
| Ordinary income | CurrentYTDDuration | -101330000 | JPY |
| Income before income taxes | Prior1YTDDuration | -26107000 | JPY |
| Income before income taxes | CurrentYTDDuration | -101330000 | JPY |
| Income taxes current | Prior1YTDDuration | 398000 | JPY |
| Income taxes current | CurrentYTDDuration | 398000 | JPY |
| Income taxes | Prior1YTDDuration | 398000 | JPY |
| Income taxes | CurrentYTDDuration | 398000 | JPY |
| Profit loss | Prior1YTDDuration | -26506000 | JPY |
| Profit loss | CurrentYTDDuration | -101729000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | -4644000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | -3867000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -21861000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -97861000 | JPY |
| Profit loss | Prior1YTDDuration | -26506000 | JPY |
| Profit loss | CurrentYTDDuration | -101729000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -569000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -127000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -569000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -127000 | JPY |
| Comprehensive income | Prior1YTDDuration | -27075000 | JPY |
| Comprehensive income | CurrentYTDDuration | -101856000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -22431000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -97988000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -4644000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -3867000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-05-12 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第26期第１四半期（自 2023年１月１日 至 2023年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社デ・ウエスタン・セラピテクス研究所 | |
| Company name in english cover page | FilingDateInstant | D.Western Therapeutics Institute, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 日 高 有 一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)名古屋市中区錦一丁目18番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 052－218－8785 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 松 原 さ や 子 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)名古屋市中区錦一丁目18番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 052－218－8785 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 松 原 さ や 子 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E22024 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45760 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社デ・ウエスタン・セラピテクス研究所 | |
| Filer name in english | FilingDateInstant | D.Western Therapeutics Institute, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |